Literature DB >> 4275226

Comparison of five aminocyclitol antibiotics in vitro against Enterobacteriaceae and Pseudomonas.

W Karney, K K Holmes, M Turck.   

Abstract

The in vitro susceptibility of 163 strains of Enterobacteriaceae and 23 isolates of Pseudomonas aeruginosa to various concentrations of gentamicin, kanamycin, spectinomycin, tobramycin, and BB-K8, a new semisynthetic aminoglycoside antibiotic, was determined. Studies were performed in Mueller-Hinton agar and broth, and two different sizes of bacterial inocula were used. On a weight basis, gentamicin and tobramycin demonstrated comparable activity in vitro and were the most active of the five drugs tested against Escherichia coli, Klebsiella, Enterobacter, and Proteus species. All of these organisms were inhibited by gentamicin or tobramycin at concentrations of 5.0 mug or less/ml in agar with both inocula of bacterial cells. In addition, tobramycin was the most active drug against isolates of P. aeruginosa and gentamicin was the most active against Salmonella and Shigella species. Although kanamycin and BB-K8 demonstrated a high degree of activity against most Enterobacteriaceae, they were not the most active agents tested for any genus. Spectinomycin was the least active compound, and many isolates grew in concentrations higher than those readily attainable in serum.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4275226      PMCID: PMC444412          DOI: 10.1128/AAC.3.3.338

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  ACUTE GONORRHEAL URETHRITIS IN MEN. TREATMENT WITH SPECTINOMYCIN SULFATE.

Authors:  J H TIEDEMANN; J F HACKNEY; E V PRICE
Journal:  JAMA       Date:  1965-01-11       Impact factor: 56.272

2.  An evaluation of a new antibiotic, actinospectacin, in infections of the urinary tract.

Authors:  R I LINDEMEYER; M TURCK; R G PETERSDORF
Journal:  Am J Med Sci       Date:  1962-10       Impact factor: 2.378

3.  Spectinomycin and penicillin G in the treatment of gonorrhea. A comparative evaluation.

Authors:  A H Pedersen; P J Wiesner; K K Holmes; C J Johnson; M Turck
Journal:  JAMA       Date:  1972-04-10       Impact factor: 56.272

4.  Enzymatic acetylation of aminoglycoside antibiotics by Escherichia coli carrying an R factor.

Authors:  R Benveniste; J Davies
Journal:  Biochemistry       Date:  1971-05-11       Impact factor: 3.162

5.  Aminoglycoside antibiotics: inactivation by phosphorylation in Escherichia coli carrying R factors.

Authors:  B Ozanne; R Benveniste; D Tipper; J Davies
Journal:  J Bacteriol       Date:  1969-11       Impact factor: 3.490

6.  Nebramycin, a new broad-spectrum antibiotic complex. II. Description of Streptomyces tenebrarius.

Authors:  C E Higgins; R E Kastner
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1967

7.  In vitro studies of tobramycin, an aminoglycoside antibiotic.

Authors:  J Dienstag; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1972-01       Impact factor: 5.191

  7 in total
  10 in total

1.  Penetration of amikacin into the aphakic eye.

Authors:  R T Kasbeer; G A Peyman; D R May; P I Homer
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1975-08-04

2.  Effects of gestational age, birth weight, and hypoxemia on pharmacokinetics of amikacin in serum of infants.

Authors:  M G Myers; R J Roberts; N J Mirhij
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

3.  Susceptibility of Pseudomonas aeruginosa to tobramycin or gentamicin alone and combined with carbenicillin.

Authors:  E L Anderson; P K Gramling; P R Vestal; W E Farrar
Journal:  Antimicrob Agents Chemother       Date:  1975-09       Impact factor: 5.191

Review 4.  Why monitor serum levels of gentamicin?

Authors:  M Barza; M Lauermann
Journal:  Clin Pharmacokinet       Date:  1978 May-Jun       Impact factor: 6.447

Review 5.  Tobramycin: a review of its antibacterial and pharmacokinetic properties and therapeutic use.

Authors:  R N Brogden; R M Pinder; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

6.  In vitro activity of netilmicin, gentamicin, and amikacin.

Authors:  R J Kantor; C W Norden
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

7.  In vitro activity of spectinomycin against recent urinary tract isolates.

Authors:  R J Fass; R B Prior
Journal:  Antimicrob Agents Chemother       Date:  1977-10       Impact factor: 5.191

8.  Activity of BB-K8 (amikacin) against clinical isolates resistant to one or more aminoglycoside antibiotics.

Authors:  K E Price; T A Pursiano; M D DeFuria
Journal:  Antimicrob Agents Chemother       Date:  1974-02       Impact factor: 5.191

9.  Newer aminoglycosides--amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamicin.

Authors:  A V Reynolds; J M Hamilton-Miller; W Brumfitt
Journal:  Br Med J       Date:  1974-09-28

10.  Activity of five aminoglycoside antibiotics in vitro against gram-negative bacilli and Staphylococcus aureus.

Authors:  L S Young; W L Hewitt
Journal:  Antimicrob Agents Chemother       Date:  1973-12       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.